Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Article
White Papers and Resources | October 1, 2020 | Inizio
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Webcast
White Papers and Resources | October 1, 2020 | Inizio
Monitoring the impact of COVID-19 on the market access landscape
Covid-19 redefines rules of customer engagement
White Papers and Resources | September 30, 2020 | Wilmington Healthcare
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
White Papers and Resources | September 30, 2020 | Impetus Digital
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians.
The concordance conundrum: understanding the complexities of behaviour change
White Papers and Resources | September 30, 2020 | Page & Page Health
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved.
The concordance conundrum: creating space for open dialogue
White Papers and Resources | September 30, 2020 | Page & Page Health
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Responding to dynamic shifts in value communications
White Papers and Resources | September 29, 2020 | OPEN Health
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.
The concordance conundrum: the tech divide
White Papers and Resources | September 28, 2020 | Page & Page Health
COVID-19 resulted in the rapid adoption of virtual consultations; while they offer increased accessibility and convenience for some, are they really all they are cracked up to be? Consultations in...
Using Artificial Intelligence to Transform Pharma
Videos and Podcasts | September 24, 2020 | Impetus Digital
Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many...